GE HealthCare Technologies (GEHC) is back in focus after missing first quarter adjusted earnings expectations, cutting full year EPS guidance, and triggering multiple securities law investigations following the post earnings share price drop.

Those earnings and guidance headlines have come on top of a sharp reset in the share price, with GE HealthCare’s 30 day share price return down 18.62% and its year to date share price return down 26.64%, while the 1 year total shareholder return is down 16.77% and the 3 year total shareholder return is down 23.01%. This points to fading momentum despite ongoing product launches in areas like AI enabled imaging and radiation therapy.

If this mix of earnings shock and healthcare AI product news has your attention, it could be a moment to scan for other potential opportunities in healthcare related AI stocks using the 32 healthcare AI stocks.

With GE HealthCare stock down sharply, yet trading below some analyst price targets and carrying a mid range value score, the key question is simple: are you looking at a discounted entry into healthcare AI or a market that already anticipates future growth?

Most Popular Narrative: 24% Undervalued

GE HealthCare’s most followed valuation narrative pegs fair value at about $79.95 per share, compared with the latest close at $60.76, putting the current reset in a very different light.

The pipeline of new high-impact products, like Radiopharmaceuticals, Total Body PET, and Photon Counting CT, is anticipated to drive future revenue growth and potentially improve margins.

Curious what kind of revenue profile and margin lift would back that $79.95 fair value, and how far earnings would need to stretch to get there? The narrative leans heavily on sustained top line growth, a step up in profitability and a future P/E multiple that sits below current medical equipment averages, all working together in one detailed forecast path.

Result: Fair Value of $79.95 (UNDERVALUED)

However, recent tariff headwinds and regulatory uncertainty in China, along with lower free cash flow, could pressure margins and limit the flexibility that optimistic scenarios assume.

Next Steps

With sentiment clearly split between concern and optimism, this is a moment to move quickly, review the detail, and weigh both sides using the 4 key rewards and 1 important warning sign.

Looking for more investment ideas?

If GE HealthCare has sharpened your focus, do not stop here. Broaden your watchlist with other focused ideas that might fit your style and risk comfort.

• Spot potential high risk, high reward opportunities by scanning 27 elite penny stocks with strong financials that already show supporting financial strength.
• Zero in on quality companies that the market may be overlooking by reviewing the screener containing 21 high quality undiscovered gems for fresh possibilities.
• Prioritize resilience and capital protection by checking the 66 resilient stocks with low risk scores that score well on stability and downside risk.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.